It has been reported that the epithelial cell adhesion molecule (EpCAM) could be used as a marker to isolate epithelial-derived EVs from the blood sample of colorectal cancer patients by immunoaffinity-capture (Ostenfeld et al., 2016). This evidence concerns the gene EPCAM and colorectal cancer.